IMR Press / EJGO / Volume 41 / Issue 2 / DOI: 10.31083/j.ejgo.2020.02.5212
Open Access Original Research
Performance of multimodal hyperspectroscopy for scanning of cervix in pregnant women: a preliminary study
Show Less
1 Gynecology and Obstetrics Department, -Istanbul School of Medicine-Istanbul University, Istanbul, Turkey
2 Perinatology Department, -Istanbul School of Medicine-Istanbul University, Istanbul, Turkey
3 Gynecologic Oncology Department-Istanbul School of Medicine-Istanbul University, Istanbul, Turkey
4 Gynecologic Oncology Department-Florence Nightingale Hospital-Istanbul Science University, Istanbul, Turkey
Eur. J. Gynaecol. Oncol. 2020, 41(2), 277–280;
Published: 15 April 2020

Purpose: This study aimed to measure the performance of cervical multimodal hyperspectroscopy (MHS) when compared to Pap smear, and HPV testing in low-risk pregnant women followed up in a university clinical setting. Materials and Methods: Each of 91 pregnant women underwent Pap smear, HPV testing, and during the first 20 weeks of pregnancy. In 84 subjects evaluable data were collected and analyzed. Results: Average age of women was 30 ± 5.2 years. The specificity of MHS performed in pregnant women seems to be significantly better (p < 0.01) than the data of non-pregnant women published earlier. The specificity of MHS in pregnant women with normal Pap smear result is estimated to be 92.9%. The procedure was also well-tolerated with a patient satisfaction rate of 92%. Conclusions: Scanning of the cervix by MHS may perform similar to Pap smear + HPV testing and may have a higher specificity in low-risk pregnant women.

Cervical multimodal hyperspectroscopy
Pap smear
HPV testing
Cervical scanning.
Back to top